JMAT stock news
This page provides real-time market news, earnings updates, and company announcements related to Johnson Matthey Plc (JMAT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-20 04:21 GMT
NeoVolta Provides Financing Update on Transformational Battery Manufacturing Joint Venture
Finviz2026-02-12 13:33:07
Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Finviz2026-02-13 15:01:05
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial
101 finance2026-02-13 19:54:35
MarketBeat Week in Review - 02/09 - 02/13
Finviz2026-02-14 12:00:47
Johnson & Johnson (JNJ) Is Amazing, Says Jim Cramer
Finviz2026-02-14 17:48:46
Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer
Finviz2026-02-14 20:42:07
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
Finviz2026-02-16 15:57:36
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
Finviz2026-02-16 15:57:36
What to Expect From These Drug/Biotech Players This Earnings Season?
Finviz2026-02-16 20:18:39
5 Essential Analyst Inquiries From Hasbro’s Fourth Quarter Earnings Discussion
101 finance2026-02-17 10:51:37
Medtronic beats quarterly profit estimates on robust demand for heart devices
101 finance2026-02-17 12:03:13
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Finviz2026-02-17 12:03:42
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
Finviz2026-02-17 12:03:44
Integra LifeSciences Announces Key Executive Leadership Appointments
Finviz2026-02-17 13:33:47
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
Finviz2026-02-17 16:48:10
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
Finviz2026-02-17 19:33:09
EyePoint Appoints Michael Campbell as Chief Commercial Officer
Finviz2026-02-18 12:03:06
Innventure Issues Statement on Commonwealth Asset Management Schedule 13D and Reiterates Commitment to Value Creation Strategy
Finviz2026-02-18 13:06:40
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Finviz2026-02-18 15:03:45
Johnson & Johnson announces an investment of over 1 billion USD to build a cutting-edge cell therapy manufacturing facility in Montgomery County, Pennsylvania.
老虎证券2026-02-18 15:47:58
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
According to sources familiar with the matter, healthcare giant Johnson & Johnson is conducting a strategic review of its orthopedics division, which may involve adjustments to the future direction of the department.
老虎证券2026-02-19 19:47:34
Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports
101 finance2026-02-19 19:54:42
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board
Finviz2026-02-19 21:12:42
Johnson & Johnson (JNJ) Is Amazing, Says Jim Cramer
Finviz2026-02-14 17:48:46
Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer
Finviz2026-02-14 20:42:07
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
Finviz2026-02-16 15:57:36
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
Finviz2026-02-16 15:57:36
What to Expect From These Drug/Biotech Players This Earnings Season?
Finviz2026-02-16 20:18:39
5 Essential Analyst Inquiries From Hasbro’s Fourth Quarter Earnings Discussion
101 finance2026-02-17 10:51:37
Medtronic beats quarterly profit estimates on robust demand for heart devices
101 finance2026-02-17 12:03:13
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Finviz2026-02-17 12:03:42
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
Finviz2026-02-17 12:03:44
Integra LifeSciences Announces Key Executive Leadership Appointments
Finviz2026-02-17 13:33:47
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
Finviz2026-02-17 16:48:10
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
Finviz2026-02-17 19:33:09
EyePoint Appoints Michael Campbell as Chief Commercial Officer
Finviz2026-02-18 12:03:06
Innventure Issues Statement on Commonwealth Asset Management Schedule 13D and Reiterates Commitment to Value Creation Strategy
Finviz2026-02-18 13:06:40
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Finviz2026-02-18 15:03:45
Johnson & Johnson announces an investment of over 1 billion USD to build a cutting-edge cell therapy manufacturing facility in Montgomery County, Pennsylvania.
老虎证券2026-02-18 15:47:58
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
According to sources familiar with the matter, healthcare giant Johnson & Johnson is conducting a strategic review of its orthopedics division, which may involve adjustments to the future direction of the department.
老虎证券2026-02-19 19:47:34
Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports
101 finance2026-02-19 19:54:42
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board
Finviz2026-02-19 21:12:42
JMAT stock price change
On the last trading day, JMAT stock closed at 2282.00 GBP, with a price change of -0.17% for the day.
Trade stock futuresJMAT stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more